The acute effect of Angiotensin Converting Enzyme inhibition (ACEi) 
INTRODUCTION
Blockade of the renin-angiotensin system (RAS) with angiotensin converting enzyme inhibitors (ACEi) is one of the most important tools for the treatment of chronic renal failure, diabetic nephropathy and a number of cardiovascular disorders, including hypertension.
The physiologic responses observed upon ACE inhibition are the result of combined effects of ACEi acting through two major pathways. On the one hand, there is inhibition of ANG II production which causes hemodynamic effects as well as the suppression of the ANG IIdependent generation of growth-promoting cytokines, free oxygen radicals, and fibrosis mediators in tissues (37). On the other hand, there is an increase in the levels of bioactive peptides that, under normal conditions, would be substrates for ACE-mediated proteolysis (11, 12) . Indeed, ACE inhibition has been reported to increase the plasmatic concentration of angiotensin 1-7, an ANG I derivative which promotes bradykinin (BK) synthesis and consequently, nitric oxide (NO • ) -dependent vasodilatation (5, 35) . Moreover, the renoprotective action of ACEi following 5/6 reduction of renal mass depends on BK synthesis since BK inhibition with HOE140 abolishes the effect (26). Furthermore, the cardioprotective effects of ACEi are significantly decreased in knockout mice lacking the endothelial NO
• synthase isoform (23).
The acute effects of ACEi on renal function have been extensively studied. Certainly, acute ACE inhibition has been reported to decrease proximal tubular Na + reabsorption (22). However, the actions of chronic pharmacological ACE inhibition are less known. The development of knock out mice selectively lacking ACE expression has contributed to distinguish the roles of systemically and locally produced ANG II (14, 19) . Despite the great significance of this model, the chronic pharmacological inhibition is still a valuable tool because it allows evaluating the system in conditions that resemble those present in humans.
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Approximately 70% of Na + reabsorption in the kidneys takes place at the proximal convoluted tubule (PCT) and 70% of it depends on bicarbonate (HCO 3 -) reabsorption, i.e., H + secretion (20) . PCT acidification is a highly regulated process which involves the activity of different systems. A large fraction of HCO 3 -reabsorption is mediated by apical membrane electroneutral Na + /H + exchange, mostly through the NHE3 isoform (4, 42, 45) . The remaining fraction (~30%) occurs through apical H + electrogenic extrusion mediated by the V-H + -ATPase (45).
Angiotensin II, NO
• and BK, all them affected by ACEi, are actively involved in the regulation of PCT function, including H + secretion (1, 29, 32, 36, 44) . The aim of the present work was to evaluate PCT acidification after chronic ACE inhibition.
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METHODS
Experimental groups.
Control: Male Wistar rats with free access to food and tap water were used three months after weaning as control. Enalapril: Enalapril (10 mg × kg -1 of body weight × day -1 ) was added to the drinking water, from weaning until the day when the kidneys were removed or the micropuncture experiments were performed, three months after the start of the treatment. The concentration of enalapril in the water was adjusted every three days according to the volume of ingested water and the body weight.
Metabolic Parameters.
Rats were weighted and placed in metabolic cages with free access to pre-weighted food containing 0.3% Na and tap water during 24 hours. Systolic blood pressure was measured by plesthymography using a pneumatic pulse transducer (Narco Bio Systems, Houston, TX, USA).
Urine sodium concentration was measured with a Na + sensitive electrode autoanalizer (Roche/Hitachi 917).
Micropuncture experiments.
The rats were anesthetized with inactin (100 mg/kg ip) and prepared for micropuncture experiments as previously described (2) . Briefly, the right jugular vein was cannulated to administer anesthesia and fluids, a cannula was placed in the trachea and the left kidney was exposed through a flank incision. The right femoral artery was also cannulated in order to monitor blood pressure using a TSD104 blood pressure transducer interfaced to a DA100 differential amplifier (Biopac Systems, Inc Goleta, CA, USA) and to collect blood samples for pH and CO 2 determination. Proximal convoluted tubules were impaled with double-barreled micropipettes, one barrel containing Sudan black-colored castor oil and the other the luminal Liquid membrane pH-sensitive microelectrodes were made as previously described (3) At the end of the experiments a blood sample from the femoral artery and a urine sample from the bladder were taken. Blood and urine pH and pCO 2 were measured with a blood gas analyzer (AADEE, Argentina). where r is the tubule radius (0.015 mm).
The following experimental procedures were performed in both control and enalapril-treated rats:
Rats received, through the jugular vein, a bolus injection of N G nitro-L-arginine methyl esther (L-NAME), 16 mg/kg of body weight. Bafilomycin (10 -6 M) was added to the luminal perfusion solution. 
Brush-border membrane vesicles preparation.
Renal cortex brush-border membrane vesicles (BBMV) from control and enalapril-treated rats were isolated using a previously described technique (17). Kidneys were removed and washed with cold HEPES-sucrose-EDTA (HSE) buffer (in mM: 50 sucrose, 10 Tris, 10 HEPES, 0.5 EDTA, pH 7.5). Cortex were separated and homogenized. After differential centrifugation, the pellet containing BBMV was dissolved in HSE buffer with protease inhibitors (aprotinine 10 µg/ml, leupeptine 10 µg/ml, pepstatin A 10 µg/ml, phenylmethylsulfonyl fluoride 2 mM and dithiothreitol 1 mM). Protein concentration was determined according to Lowry et al. (24) . The purity of brush border membrane fraction was assessed by measuring the activity of -glutamyl transferase (30), which increased 10-fold in the BBMV compared to the original homogenate. To rule out the possibility of contamination with basolateral membrane, we measured the activity of Na + /K + ATPase (33). As expected, Na + /K + ATPase activity was not detectable in BBMV.
Quantification of V-H +
ATPase.
BBMV corresponding to 100 µg protein were electrophoresed on a 10% sodium dodecylsulfate 
Quantification of NHE3.
The general procedure is similar to that described above for quantification of V-H + ATPase, with the following modifications: BBMV samples corresponding to 40 µg protein were electrophoresed on 8% SDS-PAGE. Transblots were incubated with the primary antibody (MAB against isoform NHE3 catalog number MAB3138, Chemicon International) and, subsequently, with the secondary antibody (Antibody anti-mouse IgG (H+L) Alkaline Phosphatase Conjugate, catalog number S372B from Promega Corporation).
In the blots used to quantify NHE3 as well as in those used to determine the abundance of V-H + ATPase, the bands were visualized with BCIP/NBT Color Development Substrate (Promega Corporation, Madison, WI, USA). In all cases, membranes containing the same samples were incubated with the primary antibody against -actin (Ab5), catalog number 612656 from BD Biosciences. Band intensities were determined by densitometric analysis using ScionImage program (http://www.scioncorp.com) and were normalized to -actin band intensities on the same blot (10).
Statistics.
Data are reported as means ± SEM. Statistical significance was assessed using Student's t Test for unpaired data or ANOVA with the Newman-Keuls' "a posteriori" test when more than two experimental groups were compared (J HCO3 -flux data). Differences were considered statistically significant at p < 0.05.
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RESULTS
in control and enalapril-treated rats. Urinary Na + excretion was lower in enalapril-treated than in control rats. However, in both groups Na + balance remained in equilibrium until the time when the micropuncture experiments data were collected (Na + balance was measured the day previous to the experiment). The smaller U v Na + observed in enalapril-treated rats could be due to their decreased Na + intake, mostly attributable to a decrease in food intake displayed by these rats, as can be observed by their diminished protein intake.
Effect of chronic ACE inhibition on acid-base parameters and proximal tubule acidification kinetics.
Acid-base status was evaluated in blood samples taken from animals of the different experimental groups. Chronic treatment with enalapril caused no changes in acid-base status (Table 2) but it induced a significant increase in proximal tubule acidification, raising the net bicarbonate reabsorption (J HCO3 -) 51% over the control value (Table 3) . control and enalapril-treated rats ( Fig. 1 and Table 3 ).
Effect of chronic ACE inhibition on
Effect of systemic NO
• synthesis blockade on enalapril-induced increase in proximal tubule acidification.
We tested the hypothesis that NO • was involved in the effect of chronic ACE inhibition on proximal tubule acidification kinetics. Nitric oxide synthesis was inhibited by systemic bolus injection of L-NAME during the micropuncture experiment. Addition of L-NAME did not change arterial blood pressure in any of the experimental groups (data not shown). Inhibition of NO • synthesis did not affect PCT acidification in untreated animals but it abolished the increase in J HCO3 -induced by chronic enalapril treatment ( Table 3) . The 31 kDa band, corresponding to the V-H + ATPase, was detected with a monoclonal antibody in BBMV from both, control and enalapril-treated rats. As shown in Fig. 3 , the normalized band intensities from both groups are not significantly different, indicating that chronic ACE inhibition did not affect the levels of expression of V-H + ATPase. The abundance of the NHE3 isoform of Na + /H + exchanger was also determined. The amount of NHE3 was the same in enalapril-treated compared with control animals (Fig. 4) . The quantification of the expression was performed using vesicles obtained from kidneys of three rats from each group.
Effect of chronic ACE inhibition
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DISCUSSION
The aim of this work was to study the effect of chronic ACE inhibition on proximal tubule HCO 3 -reabsorption. Since chronic ACE inhibition is the treatment of choice to deal with several renal and cardiovascular disorders in humans, it is relevant to evaluate its effects on a key mechanism for acid-base balance and sodium and volume reabsorption.
In this study, we found that chronic treatment with enalapril increased HCO 3 -reabsorption in PCT of young adult rats. This effect was abolished by intravenous bolus delivery of the NO
• synthesis inhibitor L-NAME, which decreased the J HCO3-of enalapril-treated rats to levels similar to those observed in control rats exposed to L-NAME. The HCO 3 -flux, in control animals, was not statistically changed after L-NAME. In contrast, L-NAME induced a significant fall in J HCO3-in enalapril-treated animals, which suggests that the effect of chronic ACE inhibition involves the activation of the NO • pathway. The interaction between Renin-Angiotensin System and the path of NO • has been extensively studied (8, 23, 34, 38). We have previously shown that acute perfusion of the peritubular capillaries with an antagonist of NO • synthesis caused a decrease in H + -ion flux (7, 9). Moreover, it has been demonstrated that NO • stimulates absolute and fractional reabsorption in PCT (8, 15). Thus, in the present work, the lack of effect of L-NAME on PCT acidification observed in the control rats was unexpected. A possible explanation to this conflicting result could be that the effective concentration of L-NAME at the peritubular capillaries is lower when the antagonist is administered systemically than when it is added to the peritubular perfusate. In enalapril-treated animals, where there was an increase of NOS activity, the effect of the small dose of L-NAME used could be more apparent than in the control rats.
Still, it is noteworthy that L-NAME was very close to reach a statistically significant effect (inhibition) on PCT acidification of untreated animals (p=0.05). On the other hand, NOS activity, Acute ACE inhibition has been associated with a decrease in Na + and fluid reabsorption in PCT (22). We found that Na + excretion is smaller in enalapril-treated than in control rats. This correlated to the decrease in Na + intake observed in enalapril-treated rats. This difference could result from the small food intake displayed by enalapril-treated rats, as reflected by their reduced protein intake and body weight. Although PCT acidification does not represent the totality of volume reabsorption in PCT, it drives the largest fraction of it, and thus can be used as a good approximation to the Na + and water reabsorption at this segment of the nephron (6) . It has been reported that genetically modified mice (ACE2/2), lacking renal brush border-associated ACE, display normal PCT reabsorption or even an increased fractional reabsorption (14, 19) . These results as well as our data suggest that the effects of acute ACE inhibition would be different from those caused by chronic ACE inhibition. We do not have an explanation for the increase in J HCO3-observed upon chronic ACE inhibition and the lack of effect of ACE deficiency on volume reabsorption of ACE2/2 mice. It is possible that the diminished volume load observed in ACE2/2 mice, as consequence of the fall in the single nephron glomerular filtration rate, induces a huge increase in fractional reabsorption which is not reflected in the absolute reabsorption. On the other hand, we found that our experimental pharmacological model induced an increase in NOS activity, and presumably increased NO • production to which we ascribe the effect of increased 
Perspectives and Significance:
The main point that should be emphasized is the fact that chronic and acute ACE inhibitions of the nephron were affected by ACE-inhibition in the same way (i.e., HCO 3 -and Na + loss), then we would expect chronic ACEi treatment to cause metabolic acidosis and volume contraction.
However, these side effects have not been reported in chronically ACEi-treated human patients. It would be interesting to determine whether ACE knout-out animals display changes in the NO
• pathway. and blood pH (pHb) and urine samples were taken from the bladder to measure urinary pH (pHu).
Plasmatic HCO 3 -values were calculated using pK 1 = 6.13. Control (7) 42.5 ± 1.4 27.9 ± 0.5 7.45 ± 0.01 5.9±0.013
Enalapril (7) 44.5 ± 0.9 28.4 ± 0.5 7.41 ± 0.01 6.0 ± 0.08 
